Shandong Buchang Pharmaceuticals Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shandong Buchang Pharmaceutical Co., Ltd. (referred to as "Buchang Pharmaceutical") was established in 2001 and completed its shareholding restructuring in 2012. In July 2016, it passed the IPO review by the China Securities Regulatory Commission and was successfully listed on November 18, 2016. In the past 20 years of development, Pace Pharma has built a clear development strategy, "focusing on major diseases and cultivating large varieties". With patent traditional Chinese patent medicines and simple preparations as the core, the company is committed to the modernization of traditional Chinese medicine, giving full play to the important role of traditional Chinese medicine in the field of cardiovascular and cerebrovascular diseases, and forming a three-dimensional product pattern based on the cardiovascular and cerebrovascular market, covering the traditional advantages of traditional Chinese patent medicines and simple preparations, focusing on major diseases and cultivating large varieties. Based on the theory of treating both brain and heart, Buchang Pharmaceutical has developed and cultivated three exclusive patent varieties: Naoxintong Capsules, Wenxin Granules, and Danhong Injection. The treatment scope covers common cardiovascular and cerebrovascular diseases such as stroke, arrhythmia, insufficient blood supply, and ischemic infarction. As a leading enterprise of patent prescription drugs for traditional Chinese medicine, its main products also have strong competitiveness in the fields of gynecological medicine, diabetes and cancer. The gynecological medication Honghe Fujie Lotion is a third class new national traditional Chinese medicine and an exclusive variety of the company. The company has also achieved product coverage in pediatric, anti-tumor, urinary and digestive, bone and joint, and respiratory systems, and has best-selling products such as Qianlie Shutong Capsules, Ganshuang, Kelu Oral Liquid, and Xiasangju Granules. The company can currently produce various dosage forms such as capsules, granules, and injections. In September 2018, Buchang officially announced its transformation from a marketing driven to a product driven, and to a technology driven company; From traditional Chinese patent medicines and simple preparations to biological medicine, chemical medicine, medical equipment, Internet medicine and other whole industries; Transforming from localization in China to globalization, steadily achieving the strategic planning of biopharmaceuticals. In the future, we will lay out the big health industry, based on patented traditional Chinese medicine, and actively explore biopharmaceuticals, internet medicine (mobile medicine, wearable medicine, e-commerce, etc.), health products, medical devices, hospitals, etc. With the strength and rise of China, Buchang Pharmaceutical will further deepen its global layout, striving and striving towards companies with a market value of hundreds of billions through product and enterprise mergers and acquisitions. The growth of Bu Chang Pharmaceutical benefits from the reform of China's market economy system and healthcare system, and is closely related to China's favorable investment environment. China's Johnson&Johnson, the pace of the world "is the company's vision, and the company will continue to make due contributions to regional economic development and the development of the pharmaceutical and medical industry, and give back to investors and society with excellent performance. |
| Headquarter | Heze City |
| Establish Date | 5/10/2001 |
| Listed Code | 603858.SH |
| Listed Date | 11/18/2016 |
| Chairman | Zhao Tao. |
| CEO | Zhao Chao. |
| Website | www.buchang.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
